Filter
1592
Filtered Results: 1592
Text search:
human
pharmaceutical
products
Featured
Recommendations
149
New Publications
451
Language
Document type
No document type
822
Studies & Reports
317
Guidelines
236
Manuals
81
Strategic & Response Plan
78
Fact sheets
21
Training Material
18
Situation Updates
10
Resource Platforms
4
Brochures
2
Infographics
2
Online Courses
1
Countries / Regions
Kenya
66
Global
57
Ethiopia
55
India
51
Sierra Leone
35
Nigeria
35
South Africa
35
Western and Central Europe
32
Uganda
30
Liberia
30
Rwanda
27
Ghana
26
Nepal
25
Namibia
25
Tanzania
23
Zambia
23
Ukraine
19
Philippines
19
Malawi
18
Africa
17
Bangladesh
16
Latin America and the Carribbean
14
Lesotho
13
Eastern Europe
13
Indonesia
13
Zimbabwe
12
Myanmar / Burma
12
Cambodia
11
South–East Asia Region
11
Eswatini/ Swaziland
10
Syria
9
Botswana
9
West and Central Africa
8
Eastern Europe and Central Asia
8
East and Southern Africa
7
Burkina Faso
6
Guinea
6
Asia
6
Congo, Democratic Republic of
6
Haiti
5
South Sudan
5
Cameroon
4
Albania
4
Senegal
4
Venezuela
4
Pakistan
4
North Macedonia
3
Thailand
3
China
3
Fiji
3
Laos
3
Mozambique
3
USA
3
Jordan
3
Middle East and North Africa
3
Western Pacific Region
3
North America
3
Russia
3
Sudan
3
Tajikistan
2
Serbia
2
Benin
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
Germany
2
Jamaica
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Brazil
2
Moldova
2
Egypt
2
Georgia
2
Central African Republic
2
Mali
2
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Bulgaria
1
Armenia
1
Ireland
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
United Kingdom
1
Southern Africa
1
Sri Lanka
1
Yemen
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
631
Clinical Guidelines
113
Public Health
85
Key Resources
82
Women & Child Health
42
Pharmacy & Technologies
23
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
176
Pharmacy
145
COVID-19
103
TB
76
HIV
70
Mental Health
69
NTDs
55
Rapid Response
54
Planetary Health
52
Global Health Education
38
Caregiver
29
Health Financing Toolbox
28
NCDs
28
Conflict
27
Ebola & Marburg
26
Specific Hazards
13
Refugee
10
Disability
10
Natural Hazards
8
Polio
8
Social Ethics
3
Zika
3
Cholera
1
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was...
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
The vision of the new Strategic Action Plan for Strengthening HIS in Myanmar 2017- 2021 is “A strong health information system for a strong health system”. The mission statement of HIS in Myanmar also developed during the strategic planning exercise is “Generating and making accessible compreh...
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community phar...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Accessed: 30.10.2019
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
Global Campaign Against Epilepsy
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi...
